A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Regorafenib
Related studies linked through entity extraction aliases.
A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis
- Status
- UNKNOWN
- Phase
- PHASE2
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Regorafenib in Patients With Refractory Primary Bone Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure
- Status
- UNKNOWN
- Phase
- NA
Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs
- Status
- RECRUITING
- Phase
- PHASE2
Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE2
A Clincal Study of Max-40279-01 in Patients With Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)
- Status
- COMPLETED
- Phase
- PHASE3
Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis
- Status
- RECRUITING
- Phase
- PHASE2